Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 26, 2026
Early Individualized Psychological Intervention Using Virtual Reality-assisted Decision System Reduces Decisional Conflict in Patients with Pulmonary Nodules: A Randomized Controlled TrialYuhang Hu, Qiong Wu, Xidong Jin, et al.
Journal of Pharmacological and Toxicological Methods|May 7, 2015
Long-term stability, reproducibility, and statistical sensitivity of a telemetry-instrumented dog model: A 27-month longitudinal assessmentRyan M Fryer, Khing Jow Ng, Liguo Chi, et al.
Eye (London, England)|May 28, 2024
ROBIN: a randomised, double-masked, placebo-controlled Phase IIa study of the AOC3 inhibitor BI 1467335 in diabetic retinopathyQuan Dong Nguyen, Justis P Ehlers, David S Boyer, et al.
The European Respiratory Journal|January 19, 2019
Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness <i>versus</i> tiotropium alone in COPDFrançois Maltais, Joseph-Leon Aumann, Anne-Marie Kirsten, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 26, 2011
Genomic-derived markers for early detection of calcineurin inhibitor immunosuppressant-mediated nephrotoxicityYuxia Cui, Qihong Huang, James Todd Auman, et al.
Mutation Research|May 4, 2004
Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicantsQihong Huang, Xidong Jin, Elias T Gaillard, et al.
BMJ Open Respiratory Research|December 3, 2020
The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPDFelix Herth, Jens M Hohlfeld, Johannes Haas, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2018
A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumorsMary E R O'Brien, Debashis Sarker, Jaishree Bhosle, et al.
Breast Cancer Research and Treatment|February 9, 2022
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trialTamas Hickish, Ajay Mehta, Mei-Ching Liu, et al.
Pageof 1